Advertisement
Trending - Altmetric
-
Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)
-
Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail
-
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
-
Overcoming limitations in current measures of drug response may enable AI-driven precision oncology